Medical Science Liaison, Oncology at Bristol-Myers Squibb

Seoul, South Korea, South Korea

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, OncologyIndustries

Requirements

Advanced degree in a relevant scientific field (MD, PharmD, PhD, or MSc preferred)
Experience in the pharmaceutical industry or clinical/scientific research (oncology experience preferred)
Strong understanding of the Korean healthcare environment and regulatory landscape
Excellent communication and scientific presentation skills
Ability to work independently in an agile team

Responsibilities

Build and maintain scientific partnerships with external stakeholders, including thought leaders (TLs), healthcare professionals (HCPs), payers, and health authorities
Lead scientific exchange with HCPs, ensuring medical accuracy and compliance with local procedures, ethical guidelines, and legal directives
Collect and transform field medical insights into actionable goals aligned with strategic medical plans
Stay current on scientific and clinical trends, treatment landscapes, unmet medical needs, clinical trials, and competitor activities
Implement and execute individual TL interaction plans in a timely manner
Execute field medical tactics for product launches, ensuring alignment with local regulations and ethical standards
Identify and communicate country- or population-specific medical unmet needs to inform launch strategy
Collaborate with field commercial partners to deliver integrated launch activities and ensure scientific alignment
Provide disease and product data training for internal partners as needed
Drive launch readiness and excellence by proactively supporting pre- and peri-launch activities
Support BMS-sponsored interventional and non-interventional research (NIR) studies as appropriate
Serve as the primary contact for Investigator-Sponsored Research (ISR) and non-interventional research, ensuring compliance with company and legal guidelines
Identify clinical unmet needs and translate them into data/evidence generation opportunities
Lead scientific communications with investigators on data publication and presentation

Skills

Key technologies and capabilities for this role

OncologyMedical Science LiaisonThought Leader EngagementScientific ExchangeStakeholder ManagementField MedicalProduct LaunchHealthcare ProfessionalsPayersHealth AuthoritiesMedical InsightsClinical Trends

Questions & Answers

Common questions about this position

What benefits does Bristol Myers Squibb offer?

Bristol Myers Squibb offers a wide variety of competitive benefits, services, and programs that provide employees with resources to pursue their goals both at work and in their personal lives.

Is this Medical Science Liaison role remote or field-based?

The role is field-based, focusing on developing relationships with thought leaders in Korea.

What are the key responsibilities for this MSL position?

Key responsibilities include external stakeholder engagement with thought leaders and HCPs, executing field medical tactics for product launches, and supporting data generation through research studies.

What is the company culture like at Bristol Myers Squibb?

The culture emphasizes challenging, meaningful, life-changing work in an agile team environment with high-achieving teams, balance, flexibility, and opportunities for growth.

What makes a strong candidate for the MSL Oncology role?

Strong candidates will have expertise in scientific exchange, ability to build partnerships with thought leaders and HCPs, knowledge of oncology trends and clinical trials, and experience supporting product launches.

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free